Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

excella gmbh - azatioprina - azatioprina....50.00 mg

United States - English - NLM (National Library of Medicine)

excella gmbh & co. kg - deracoxib (unii: vx29jb5xwv) (deracoxib - unii:vx29jb5xwv) -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

excella gmbh & co.kg - melphalan - tablets film-coated - 2mg

United States - English - NLM (National Library of Medicine)

excella gmbh - emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s) - emtricitabine 200 mg - emtriva® is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. additional important information regarding the use of emtriva for the treatment of hiv-1 infection: - emtriva should not be coadministered with atripla® , truvada® , or lamivudine-containing products [see warnings and precautions (5.3)]. - in treatment-experienced patients, the use of emtriva should be guided by laboratory testing and treatment history [see clinical pharmacology (12.4)]. emtriva is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the products. pregnancy category b the incidence of fetal variations and malformations was not increased in embryofetal toxicity studies performed with emtricitabine in mice at exposures (auc) approximately 60-fold higher and in rabbits at approximately 120-fold higher than human exposures at the recommended daily dose. there are, however, no adequate and well-controlled studies in pregnant women. because an

United States - English - NLM (National Library of Medicine)

excella gmbh - adefovir dipivoxil (unii: u6q8z01514) (adefovir - unii:6gqp90i798) - adefovir 10 mg - hepsera is indicated for the treatment of chronic hepatitis b in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (alt or ast) or histologically active disease. this indication is based on histological, virological, biochemical, and serological responses in adult patients with hbeag+ and hbeag- chronic hepatitis b with compensated liver function, and with clinical evidence of lamivudine-resistant hepatitis b virus with either compensated or decompensated liver function. for patients 12 to <18 years of age, the indication is based on virological and biochemical responses in patients with hbeag+ chronic hepatitis b virus infection with compensated liver function. hepsera is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies of hepsera in pregnant women. chroni

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

excella gmbh & co.kg - melphalan - tablets film-coated - 2mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - methotrexate -

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - chlorambucil - tablets - chlorambucil 2 mg - chlorambucil - leukeran is indicated in the treatment of hodgkin's disease, indolent non-hodgkin's lymphoma, chronic lymphocytic leukaemia, and waldenstrom's macroglobulinaemia